Search Results - "STORM, F. K"

Refine Results
  1. 1

    Clinical hyperthermia and chemotherapy by Storm, F K

    Published in The Radiologic clinics of North America (01-05-1989)
    “…Hyperthermia may act additively or synergistically with a majority of clinically useful chemotherapeutic agents in vitro. In some cases enhanced responses are…”
    Get more information
    Journal Article
  2. 2

    cDNA sequence of a human heat shock protein HSP27 by CARPER, S. W, ROCHELEAU, T. A, STORM, F. K

    Published in Nucleic acids research (11-11-1990)
    “…We report here the sequence of a cDNA lambda phage contained in a library derived from polyA RNA isolated from A549 human lung carcinoma cells 4 hrs after a 45…”
    Get full text
    Journal Article
  3. 3

    Lack of association between tumor necrosis and hsp-27 expression in primary breast cancer by Storm, F. Kristian, Mahvi, David M., Gilchrist, Kennedy W.

    Published in Journal of surgical oncology (01-01-1996)
    “…Overexpression of heat shock protein 27 (hsp‐27) is associated with reduced disease‐free survival in early stage breast cancer. Histopathologic evidence of…”
    Get full text
    Journal Article
  4. 4

    Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity by Storm, F K, Morton, D L

    Published in The American journal of surgery (01-07-1985)
    “…Twenty-six patients with advanced melanoma metastases confined to the lower extremity underwent 28 therapeutic limb perfusions without a major complication or…”
    Get more information
    Journal Article
  5. 5

    Cellular effects of piezoelectric versus electrohydraulic high energy shock waves by Smith, F L, Carper, S W, Hall, J S, Gilligan, B J, Madsen, E L, Storm, F K

    Published in The Journal of urology (01-02-1992)
    “…High energy shock waves produced by a piezoelectric lithotripter, (EDAP LT.01) and an electrohydraulic lithotripter, (Dornier HM3) were examined for their…”
    Get more information
    Journal Article
  6. 6

    Histologic features relating to prognosis in synovial sarcoma by Cagle, L A, Mirra, J M, Storm, F K, Roe, D J, Eilber, F R

    Published in Cancer (15-05-1987)
    “…Although the American Joint Commission has classified all synovial sarcomas as "high grade," histologic subtypes can be identified. By histologically…”
    Get more information
    Journal Article
  7. 7

    Evaluation of hypoxia and acidosis on the cytotoxicity of the stereoisomers of tetraplatin at normal and hyperthermic temperatures by Carper, S W, Storm, F K

    “…Tetraplatin is a second-generation platinum analogue that will be introduced into clinical trials during 1990. We have evaluated the cytotoxicity of…”
    Get more information
    Journal Article
  8. 8

    Effects of interleukin-2 on pulmonary and systemic transvascular fluid filtration by Harms, B A, Pahl, A C, Pohlman, T H, Conhaim, R L, Starling, J R, Storm, F K

    Published in Surgery (01-08-1989)
    “…Interleukin-2 (IL-2) therapy for patients with advanced cancer may be compromised by dose-limiting and life-threatening pulmonary and systemic edema. We…”
    Get more information
    Journal Article
  9. 9

    Induction of transient hyperglycaemia in cancer patients by Krag, D N, Storm, F K, Morton, D L

    “…Serum glucose levels up to 700 mg/dl were achieved and maintained for 3 h in patients with advanced metastatic cancer by infusion of concentrated glucose…”
    Get more information
    Journal Article
  10. 10

    Diagnosis and management of retroperitoneal soft-tissue sarcoma by KRISTIAN STORM, F, MAHVI, D. M

    Published in Annals of surgery (01-07-1991)
    “…Retroperitoneal soft-tissue sarcomas are locally invasive tumors that remain occult for long periods and grow quite large due to the abdominal cavity's…”
    Get full text
    Journal Article
  11. 11

    Interleukin-2 Does Not Sequester Activated Lymphocytes into Lung Lymph of Sheep by Mahvi, David M., Conhaim, Robert L., Harms, Bruce A., Storm, F.Kristian

    Published in The Journal of surgical research (01-01-1996)
    “…Purpose of study: Interleukin-2 (IL-2) is a potent activator of lymphocytes, but its effectiveness as an anticancer agent is compromised by several adverse…”
    Get full text
    Journal Article
  12. 12

    Technical details of intraoperative lymphatic mapping for early stage melanoma by Morton, D L, Wen, D R, Wong, J H, Economou, J S, Cagle, L A, Storm, F K, Foshag, L J, Cochran, A J

    Published in Archives of surgery (Chicago. 1960) (01-04-1992)
    “…The initial route of metastases in most patients with melanoma is via the lymphatics to the regional nodes. However, routine lymphadenectomy for patients with…”
    Get more information
    Journal Article
  13. 13

    Natural history of surgically treated mucosal melanoma by Wong, J H, Cagle, L A, Storm, F K, Morton, D L

    Published in The American journal of surgery (01-07-1987)
    “…Thirty-three patients with melanoma arising in a mucosal site were reviewed. Sixteen patients were treated either with abdominoperineal resection or radical…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Pulmonary and systemic fluid filtration after continuous versus bolus interleukin-2 infusion by Harms, B A, Rosenfeld, D J, Conhaim, R L, Pahl, A C, Subramanian, R, Storm, F K

    Published in Surgery (01-09-1991)
    “…Interleukin-2 has been widely investigated as adjuvant therapy for advanced cancer and is administered by either bolus or continuous infusion. We compared the…”
    Get more information
    Journal Article
  16. 16

    An unusual presentation of metastatic squamous cell carcinoma of the vulva by Steele, D M, Hegstrand, L R, Julian, T M, Storm, F K

    Published in Gynecologic oncology (01-11-1990)
    “…Recurrent squamous cell cancer of the vulva metastasized via regional lymphatics. Hematogenous spread is late and unusual. A patient with metastatic disease…”
    Get more information
    Journal Article
  17. 17

    Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients by Storm, F K, Baker, H W, Scanlon, E F, Plenk, H P, Meadows, P M, Cohen, S C, Olson, C E, Thomson, J W, Khandekar, J D, Roe, D

    Published in Cancer (01-06-1985)
    “…Nine US institutions performed 14,807 Phase I-II treatments of magnetic-induction (Magnetrode [Henry Medical Electronics, Inc., Los Angeles, CA]) hyperthermia…”
    Get more information
    Journal Article
  18. 18

    Loosely coupled coaxial TEM applicators for deep-heating by Harrison, W H, Storm, F K

    “…The development of a coaxial TEM (transverse electromagnetic) deep-heating, non-contacting applicator employing two axially spaced concentric sleeves is…”
    Get more information
    Journal Article
  19. 19

    Hyperthermia: Electromagnetic Heating of Deep-Seated Tumors by Elliott, R. S., Harrison, W. H., Storm, F. K.

    “…Alternate methods for producing electromagnetic heating of deep-seated tumors are compared, with the focus on techniques which involve the use of a…”
    Get full text
    Journal Article
  20. 20

    Heat shock protein 27 overexpression in breast cancer lymph node metastasis by Storm, F K, Mahvi, D M, Gilchrist, K W

    Published in Annals of surgical oncology (01-11-1996)
    “…Heat shock protein 27 (hsp-27) is overexpressed in approximately 67% pure ductal carcinoma in situ (DCIS), in approximately 50% DCIS associated with invasive…”
    Get full text
    Journal Article